Storm Therapeutics
Small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer
Seedtable Score
37
Startups
5
Funding Rounds
$157.6m
Money raised
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Storm Therapeutics has raised a total of $133.8m in funding over 5 rounds.
Key Insights:
- STORM Therapeutics Series C Round, April 2026: $56m
- Storm Therapeutics December 2022 Series B Funding Round: $30m
- Storm Therapeutics - Series B round, December 2022: $30m
- Storm Therapeutics Series A round, May 2019: $17.8m
- Storm Therapeutics funding round, January 2018: $5.4m
STORM Therapeutics Series C Round, April 2026
$56m
Storm Therapeutics December 2022 Series B Funding Round
$30m
Storm Therapeutics - Series B round, December 2022
$30m
Storm Therapeutics Series A round, May 2019
$17.8m
Storm Therapeutics funding round, January 2018
$5.4m
Industries
Storm Therapeutics is active in the following industries: